Sodium Cyanate
917-61-3N#C[O-].[Na+]ZVCDLGYNFYZZOK-UHFFFAOYSA-MSodium cyanate is a cyanate salt and a one-carbon compound.
917-61-3DTXSID2061274CHEMBL1644696CHEBI:38906Large Crystals
Colorless solid; [Merck Index] Beige powder; [Aldrich MSDS]
化学的特性white powder or crystals
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
Warning
H302: Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P273, P301+P317, P330, and P501 (click each P-code to see the statement)
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P273, P301+P317, P330, and P501 (click each P-code to see the statement)
Chemical: Cyanic acid, sodium salt
Cyanic acid, sodium salt (1:1) is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Cyanic acid, sodium salt (1:1) are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)
REACH registered substance: Sodium cyanate (EC: 213-030-6)
Sodium cyanate: Does not have an individual approval but may be used under an appropriate group standard
Effects on liver (decreased enzyme activity without histopathological changes), blood (increased hematocrit and reticulocytes), male reproductive organs (degeneration of germinal epithelium in the testes), and possible signs of neurotoxicity (reduced activity, impaired coordination, and clonic seizures) observed in 28-day gavage study of rats; Changes in blood interpreted as compensation to increase tissue oxygenation; Following recovery period of six weeks, hematological and neurological effects resolved; High-dose group lowered from 316 to 237 mg/kg/day due to mortality of three animals; [EPA] Causes convulsions in intramuscular LD50 study of rats; Causes degenerative changes to brain and flaccid paralysis without anesthesia in 60-day intramuscular intermittent study of monkeys (2,400 mg/kg); Causes meningeal changes in 60-day subcutaneous intermittent study of monkeys (1,500 mg/kg); Causes flaccid paralysis, somnolence, and other changes to the liver in 3-day oral intermittent study of guinea pigs; (300 mg/kg); Causes abnormal liver function tests in 26-week study of rats at >182 mg/kg; [RTECS] May cause irritation; Harmful by ingestion; [Aldrich MSDS] See Potassium cyanate and Silver cyanate.
Acute Tox. 4 (100%)
Acute toxicity - category 4
Acute toxicity (Oral) - Category 4
Acute Tox. 4 *
Used in experimental treatment of sickle cell anemia; [Merck Index] Used as an intermediate in organic synthesis; [EPA] Used in heat treatment of steel; [Hawley]
Heat Treating [Category: Heat or Machine]
Fabricated Metal Product Manufacturing
Cyanic acid, sodium salt (1:1): ACTIVE
用途有機合成原料や鋼の窒化処理、除草剤として使用される。日本では1957年3月30日に農薬登録を受け、「シアノット」「シアノン」などの商品名で販売されている。畑や林、果樹園、非農耕地の一年生雑草に茎葉に接触して枯らす。
使用Sodium Cyanate is used in biological study as tumor cell proliferation and metabolism inhibition.
純化方法It forms colourless needles from EtOH. Its solubility in EtOH is 0.22g/100g at 0oC. It is soluble in H2O but can be recrystallised from small volumes of it.